SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-15-001535
Filing Date
2015-08-05
Accepted
2015-08-05 07:00:15
Documents
7
Period of Report
2015-08-05

Document Format Files

Seq Description Document Type Size
1 6-K v416878_6k.htm 6-K 16883
2 MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION v416878_ex99-1.htm EX-99.1 150185
3 CONSOLIDATED FINANCIAL STATEMENTS v416878_ex99-2.htm EX-99.2 282163
4 MATERIAL CHANGE REPORT DATED AUGUST 5, 2015 v416878_ex99-3.htm EX-99.3 114562
5 CERTIFICATE OF FILING - CEO v416878_ex99-4.htm EX-99.4 10741
6 CERTIFICATE OF FILING - CFO v416878_ex99-5.htm EX-99.5 11423
7 GRAPHIC tex993_pg2.jpg GRAPHIC 17035
  Complete submission text file 0001279569-15-001535.txt   610675
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 151027420
SIC: 2834 Pharmaceutical Preparations